Divi's Laboratories Limited (DIVISLAB.BO)
INR 5389.5
(2.42%)
INR 5389.5
(2.42%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 16 Billion INR | -12.28% |
| 2022 | 18.24 Billion INR | -38.39% |
| 2021 | 29.6 Billion INR | 49.19% |
| 2020 | 19.84 Billion INR | 44.15% |
| 2019 | 13.76 Billion INR | 1.76% |
| 2018 | 13.52 Billion INR | 54.24% |
| 2017 | 8.77 Billion INR | -17.3% |
| 2016 | 10.6 Billion INR | -5.81% |
| 2015 | 11.25 Billion INR | 32.21% |
| 2014 | 8.51 Billion INR | 10.11% |
| 2013 | 7.73 Billion INR | 28.46% |
| 2012 | 6.02 Billion INR | 12.89% |
| 2011 | 5.33 Billion INR | 24.23% |
| 2010 | 4.29 Billion INR | 26.13% |
| 2009 | 3.4 Billion INR | -18.31% |
| 2008 | 4.16 Billion INR | 19.86% |
| 2007 | 3.47 Billion INR | 87.02% |
| 2006 | 1.85 Billion INR | 167.29% |
| 2005 | 695.34 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 4.3 Billion INR | -19.02% |
| 2023 Q3 | 3.63 Billion INR | 4.31% |
| 2023 FY | 16 Billion INR | -12.28% |
| 2023 Q2 | 3.48 Billion INR | -2.25% |
| 2023 Q1 | 3.56 Billion INR | 10.91% |
| 2023 Q4 | 5.31 Billion INR | 46.28% |
| 2022 Q3 | 3.1 Billion INR | -37.12% |
| 2022 FY | 18.24 Billion INR | -38.39% |
| 2022 Q1 | 7.02 Billion INR | -21.53% |
| 2022 Q2 | 4.93 Billion INR | -29.77% |
| 2022 Q4 | 3.2 Billion INR | 3.54% |
| 2021 Q2 | 6.06 Billion INR | 8.86% |
| 2021 Q3 | 9.02 Billion INR | 48.77% |
| 2021 Q4 | 8.94 Billion INR | -0.84% |
| 2021 FY | 29.6 Billion INR | 49.19% |
| 2021 Q1 | 5.57 Billion INR | 10.97% |
| 2020 FY | 19.84 Billion INR | 44.15% |
| 2020 Q4 | 5.02 Billion INR | 6.67% |
| 2020 Q3 | 4.7 Billion INR | -9.42% |
| 2020 Q2 | 5.19 Billion INR | 5.59% |
| 2020 Q1 | 4.92 Billion INR | 26.74% |
| 2019 FY | 13.76 Billion INR | 1.76% |
| 2019 Q3 | 3.59 Billion INR | 0.65% |
| 2019 Q2 | 3.56 Billion INR | 30.96% |
| 2019 Q4 | 3.88 Billion INR | 8.11% |
| 2019 Q1 | 2.72 Billion INR | -6.69% |
| 2018 Q1 | 2.67 Billion INR | 0.0% |
| 2018 FY | 13.52 Billion INR | 54.24% |
| 2018 Q4 | 2.91 Billion INR | -25.02% |
| 2018 Q3 | 3.89 Billion INR | -3.55% |
| 2018 Q2 | 4.03 Billion INR | 50.83% |
| 2017 FY | 8.77 Billion INR | -17.3% |
| 2016 FY | 10.6 Billion INR | -5.81% |
| 2015 FY | 11.25 Billion INR | 32.21% |
| 2014 Q4 | 2.31 Billion INR | 0.0% |
| 2014 FY | 8.51 Billion INR | 10.11% |
| 2013 Q4 | 1.96 Billion INR | 0.0% |
| 2013 FY | 7.73 Billion INR | 28.46% |
| 2012 Q4 | 1.8 Billion INR | 0.0% |
| 2012 FY | 6.02 Billion INR | 12.89% |
| 2011 FY | 5.33 Billion INR | 24.23% |
| 2010 FY | 4.29 Billion INR | 26.13% |
| 2009 FY | 3.4 Billion INR | -18.31% |
| 2008 FY | 4.16 Billion INR | 19.86% |
| 2007 FY | 3.47 Billion INR | 87.02% |
| 2006 FY | 1.85 Billion INR | 167.29% |
| 2005 FY | 695.34 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | -159.816% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 49.574% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | -239.784% |
| Granules India Limited | 4.05 Billion INR | -294.76% |
| Indoco Remedies Limited | 984.6 Million INR | -1525.024% |
| Achyut Healthcare Limited | 5.73 Million INR | -279034.682% |
| Ajanta Pharma Limited | 8.16 Billion INR | -96.038% |
| Alkem Laboratories Limited | 17.95 Billion INR | 10.902% |
| Alpa Laboratories Limited | 167.76 Million INR | -9437.15% |
| Brooks Laboratories Limited | -195.91 Million INR | 8266.64% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -890.651% |
| Bajaj HealthCare Limited | -837.93 Million INR | 2009.465% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -2020.494% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 71.266% |
| Eris Lifesciences Limited | 3.91 Billion INR | -308.181% |
| FDC Limited | 3.05 Billion INR | -424.206% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 206.548% |
| Gufic Biosciences Limited | 861.35 Million INR | -1757.536% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -280.082% |
| Ipca Laboratories Limited | 5.47 Billion INR | -192.318% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -7022.824% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 8210.136% |
| Lasa Supergenerics Limited | -217.3 Million INR | 7462.889% |
| Laurus Labs Limited | 1.6 Billion INR | -896.574% |
| Lupin Limited | 19.14 Billion INR | 16.426% |
| Mankind Pharma Limited | 19.12 Billion INR | 16.357% |
| Medicamen Biotech Limited | 109.31 Million INR | -14537.27% |
| Medico Remedies Limited | 82.9 Million INR | -19198.267% |
| Megasoft Limited | -127.46 Million INR | 12652.367% |
| NATCO Pharma Limited | 13.88 Billion INR | -15.249% |
| Piramal Pharma Limited | 178.2 Million INR | -8878.676% |
| RPG Life Sciences Limited | 876.6 Million INR | -1725.234% |
| Sigachi Industries Limited | 571.8 Million INR | -2698.171% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 83.292% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -432.835% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -6220.563% |
| Unichem Laboratories Limited | -704.74 Million INR | 2370.331% |
| Wanbury Limited | 559.56 Million INR | -2759.374% |
| Windlas Biotech Limited | 581.87 Million INR | -2649.755% |
| ZIM Laboratories Limited | 172.46 Million INR | -9177.298% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 58.544% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 513.208% |
| Hester Biosciences Limited | 188.89 Million INR | -8370.538% |
| Procter & Gamble Health Limited | 2 Billion INR | -696.099% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -3457.722% |
| Bal Pharma Limited | 73.92 Million INR | -21544.436% |
| Strides Pharma Science Limited | -706.14 Million INR | 2365.84% |
| Venus Remedies Limited | 284.9 Million INR | -5515.848% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -637.66% |
| Nectar Lifesciences Limited | 49.95 Million INR | -31932.032% |
| Shilpa Medicare Limited | 318.74 Million INR | -4919.734% |
| Aarti Drugs Limited | 1.71 Billion INR | -833.39% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -1090.211% |
| Suven Life Sciences Limited | -1.05 Billion INR | 1622.703% |
| Ind-Swift Limited | 142.31 Million INR | -11142.824% |
| Valiant Laboratories Limited | 3.19 Million INR | -500525.782% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | -189.526% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 381.993% |
| Themis Medicare Limited | 435.23 Million INR | -3576.15% |
| Hikal Limited | 696.02 Million INR | -2198.785% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 3.404% |
| Sequent Scientific Limited | -358.69 Million INR | 4560.676% |
| Novartis India Limited | 851.9 Million INR | -1778.155% |
| Wockhardt Limited | -4.63 Billion INR | 445.572% |
| Jubilant Pharmova Limited | 771 Million INR | -1975.227% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -225506.317% |
| Neuland Laboratories Limited | 3 Billion INR | -433.193% |
| Morepen Laboratories Limited | 961.59 Million INR | -1563.895% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -10857.853% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 17737.268% |